+Vote!
My Green Meadows (Free subscription) | 5 hours ago
All bow to The Onion! clipped from www.theonion.com Wyeth Pharmaceuticals unveiled a new pain-causing line of Advil this week that will help millions of benumbed, hollow consumers to feel at least somewhat alive for up to four hours. “Advil Release delivers a soothing burst of pain when cold and listless Americans need it most,” Wyeth CEO [...]
+Vote!
PR News Wire (Free subscription) | 11/20/2008
Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products, nutritionals and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer...
+Vote!
The Business Journal of the Greater Triad Aera (Free subscription) | 11/20/2008
Pharmaceutical company Wyeth will lay off 124 workers at its facility in Sanford, a company spokesman confirmed Wednesday. (WYE)
+Vote!
NewsObserver.com - Business (Free subscription) | 11/20/2008
Few options exist for those laid off.
+Vote!
News & Observer (Free subscription) | 11/19/2008
Wyeth Pharmaceuticals followed through on restructuring plans announced in January and laid off 124 employees at its vaccine manufacturing plant in Sanford.
+Vote!
The Triangle Business Journal (Free subscription) | 11/19/2008
Pharmaceutical company Wyeth will lay off 124 workers at its facility in Sanford, a company spokesman confirmed Wednesday. (WYE)
+Vote!
Teresa Lo | InVivoAnalytics.com (Free subscription) | 11/19/2008
Standard & Poor’s announced component changes to the S&P 500 Index and S&P 100 Index. Anheuser-Busch has been replaced by Wyeth (NYSE:WYE) in the S&P 100 Index. Anheuser-Busch has been replaced by Stericycle, Inc. (NASD:SRCL) in the S&P 500 Index. Applied Biosystems Inc. will be replaced by Life Technologies Corp. (NASD:LIFE) in the S&P 500 Index. Wyeth (WYE) Daily [...]
+Vote!
TortsProf Blog (Free subscription) | 11/19/2008
You can see a chat with Diana Levine, the plaintiff whose case frames the preemption issue in Wyeth v. Levine, here. --BC
+Vote!
Pharmalot (Free subscription) | 11/19/2008
The drugmakers allegedly engaged in deceptive trade practices as they went about selling four hormone therapy meds, according to a lawsuit filed in Clark County District Court in Las Vegas. Attorney General Cortez Masto claims Nevada consumers and doctors were misled about the safety of Wyeth’s Premarin, Prempro and Premphase, and Pfizer’s Provera. “When drug companies [...]
+Vote!
Pharmalot (Free subscription) | 11/18/2008
The drugmaker is eliminating 70 positions at its Pearl River, New York, facility, which employs 3,200 people, and 118 workers at its Rouses Point plant in upstate New York, where 725 people work. The cutbacks are hardly surprising, though, as Wyeth looks to reduce by 6 percent its global workforce of appoximately 50,000 employees by [...]
+Vote!
Firedoglake (Free subscription) | 11/18/2008
What if big corporations didn’t have to worry about making safe products because they knew they couldn’t be taken to court even if their products caused serious harm? These are the stakes in Wyeth v. Levine, which was argued in front of the Supreme Court on November 3rd, and is one of the most important consumer rights cases to come along in years.
+Vote!
Drug and Device Law (Free subscription) | 11/18/2008
Professor Richard Epstein, of The University of Chicago Law School, has this article about Wyeth v. Levine in this week's issue of Forbes. Professor Epstein favors preemption, but he thinks that Wyeth's position does not go far enough: Wyeth seeks preemption only because of a conflict between the warnings that the FDA required and the warnings that Levine insisted were necessary. Epstein prefers "field...
+Vote!
Medical News Today (Free subscription) | 11/18/2008
The Center for Healthcare Supply Chain Research and Wyeth Pharmaceuticals honored Ken Couch, President of Smith Drug Company, with the 2008 NEXUS Award for Lifetime Achievement at the recent HDMA 2008 Annual Leadership Forum in National Harbor, Maryland.
+Vote!
SeekingAlpha.com (Free subscription) | 11/18/2008
Derek Lowe submits: There was a legal ruling last week in California that we’re going to hear a lot more of in this business. Conte v. Wyeth (WYE). This case involved metaclopramide , which was sold by Wyeth as Reglan before going off-patent in 1982 . The plaintiff had been prescribed the generic version of the drug, was affected by a rare and serious neurological side effect (tardive dyskinesia,...
